Products for Research Use Only
RegisterLogin

Targeted gene activation

CRISPRa Kits for Programmable Endogenous Gene Activation

CRISPRa kits use catalytically inactive or modified CRISPR proteins fused to transcriptional activators to increase expression from endogenous genomic loci without creating a conventional double-strand break. Researchers use them for gain-of-function studies, pathway analysis, cell-state engineering and pooled or arrayed screens. Compare kits by dCas platform, activator architecture, guide format, promoter-targeting strategy, delivery method, cell compatibility, control set, selection system and scale.

Browse productsSelection guideFAQs

Product catalog

Browse CRISPRa Kits

Compare product names, catalog numbers, available sizes, pricing, and product specifications.

How does CRISPR activation work?

CRISPR activation directs a DNA-binding Cas complex to regulatory regions near a target gene. Because the nuclease is inactive, the complex recruits transcriptional activation machinery rather than cleaving DNA. Systems differ in the number, identity and recruitment strategy of their activation domains.

Researchers use CRISPRa to activate endogenous genes while preserving native genomic context and transcript isoforms more effectively than some complementary-DNA overexpression approaches. Applications include functional genomics, pathway discovery, cellular reprogramming and identification of genes that alter drug or stress responses.

Activation strength depends on guide position, chromatin accessibility, basal expression, cell type and activator design. Multiple guides may need to be tested around a transcription start site. Messenger RNA and protein should be measured independently, and non-targeting plus positive activation controls are important for interpretation.

Buying and selection guide

How to choose a CRISPRa kit

Match the activation architecture to the cell model and required scale. Guide placement near the correct transcription start site is often as important as the activator itself.

01

Choose the activator system

Compare single-domain and multicomponent architectures for expected strength, complexity and delivery size.

02

Define the target transcript

Identify the relevant transcription start site and isoform before guide design.

03

Match delivery to the cells

Select plasmid, viral, RNA or stable-cell approaches appropriate for the model.

04

Plan guide screening

Test several guides because activation varies strongly with position and chromatin context.

05

Include activation controls

Use non-targeting guides and a positive-control locus known to respond in the chosen cells.

06

Measure multiple endpoints

Confirm transcript, protein and relevant phenotype rather than assuming activation from guide delivery.

Frequently asked questions about CRISPRa kits

These questions cover dCas activators, guide placement, controls and differences from conventional overexpression.

What is CRISPRa?

CRISPR activation uses a DNA-targeted, nuclease-inactive Cas system connected to transcriptional activators. It increases expression from an endogenous locus without relying on standard DNA cleavage.

How is CRISPRa different from cDNA overexpression?

CRISPRa stimulates the native gene and may preserve endogenous transcript processing and regulatory context. cDNA overexpression introduces an external coding sequence and can produce expression independent of the native promoter.

Where should CRISPRa guides target?

Guides are generally designed around promoter and transcription-start-site regions, but the optimal window depends on the system and gene. Several candidates should be tested.

Why is my target gene not activated?

The guide may be poorly positioned, the locus may be inaccessible, the activator may be weak in that cell type or delivery may be inefficient. Confirm expression of the CRISPRa machinery and test multiple guides.

Can CRISPRa activate a gene that is completely silent?

Sometimes, but tightly repressed chromatin can limit access and activation. Stronger architectures, multiple guides or a different cell context may be required. Success should be determined experimentally.

What controls should be included?

Use non-targeting guides, mock delivery and a positive-control guide targeting a responsive gene. Measure baseline expression and monitor effects of the delivery system itself.

Does CRISPRa change genomic DNA?

The intended mechanism does not require cleavage or sequence modification, but off-target binding and rare unintended events should still be considered. The exact system and delivery method influence risk.

How should activation be confirmed?

Measure target messenger RNA and, when relevant, protein and phenotype. Transcript induction alone may not translate into a functional protein response.

Related Gene Expression categories

AAV Control ParticlesAntibody Purification ReagentscDNA Synthesis KitsCompetent CellsCRISPR AccessoriesDNA Sequencing PrimersKnockout KitsqPCR Primer PairsqPCR Primer PanelsqPCR Reagents